- Home
- NKTR vs RCAT Comparison
NKTR vs RCAT Comparison
Compare NKTR & RCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- RCAT
- Stock Information
- Founded
- NKTR 1990
- RCAT 2002
- Country
- NKTR United States
- RCAT United States
- Employees
- NKTR N/A
- RCAT N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- RCAT Wholesale Distributors
- Sector
- NKTR Health Care
- RCAT Industrials
- Exchange
- NKTR Nasdaq
- RCAT Nasdaq
- Market Cap
- NKTR 108.3M
- RCAT N/A
- IPO Year
- NKTR 1994
- RCAT 2017
- Fundamental
- Price
- NKTR $24.25
- RCAT $8.48
- Analyst Decision
- NKTR Strong Buy
- RCAT Buy
- Analyst Count
- NKTR 6
- RCAT 1
- Target Price
- NKTR $81.67
- RCAT $13.00
- AVG Volume (30 Days)
- NKTR 4.8M
- RCAT 10.9M
- Earning Date
- NKTR 08-07-2025
- RCAT 08-07-2025
- Dividend Yield
- NKTR N/A
- RCAT N/A
- EPS Growth
- NKTR N/A
- RCAT N/A
- EPS
- NKTR N/A
- RCAT N/A
- Revenue
- NKTR $87,248,000.00
- RCAT $2,291,089.00
- Revenue This Year
- NKTR N/A
- RCAT $1,023.35
- Revenue Next Year
- NKTR N/A
- RCAT $88.95
- P/E Ratio
- NKTR N/A
- RCAT N/A
- Revenue Growth
- NKTR N/A
- RCAT N/A
- 52 Week Low
- NKTR $6.48
- RCAT $1.43
- 52 Week High
- NKTR $37.38
- RCAT $15.27
- Technical
- Relative Strength Index (RSI)
- NKTR 63.40
- RCAT 45.47
- Support Level
- NKTR $21.87
- RCAT $6.69
- Resistance Level
- NKTR $26.59
- RCAT $7.06
- Average True Range (ATR)
- NKTR 4.14
- RCAT 0.39
- MACD
- NKTR 0.01
- RCAT -0.11
- Stochastic Oscillator
- NKTR 54.77
- RCAT 14.58
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.